Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

NCT06972680 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Shoulder Arthroscopy

Interventions

DRUG: Bupivacaine Liposomes(BL)

Sponsor

Affiliated Hospital of Jiaxing University